uniQure (QURE) Gross Margin (2021 - 2026)

uniQure's (QURE) quarterly Gross Margin came in at 93.85% in Q1 2026, up 642.0% year-on-year from 12.65% in Q1 2025, and up 1.81% quarter-over-quarter from 92.19% in Q4 2025.

uniQure (QURE) Gross Margin (2021 - 2026) Analysis & Trends

uniQure's Gross Margin history runs 6 years deep, the most recent figure standing at 93.85% for Q1 2026.

  • On a quarterly basis, Gross Margin rose 642.0% year-over-year to 93.85% in Q1 2026; TTM through Mar 2026 was 90.56%, a 7768.0% increase from a year earlier, with the FY2025 full-year figure at 89.53%, up 5243.0% from the prior year.
  • Gross Margin improved to 93.85% in Q1 2026 per QURE's latest filing, from 92.19% in the prior quarter.
  • Across five years, Gross Margin topped out at 170.68% in Q4 2023 and bottomed at 214.35% in Q4 2024.
  • The 5-year median for Gross Margin is 77.16% (2024), against an average of 47.81%.
  • Across the five-year window, Gross Margin plunged 38503 bps in 2024 and jumped 30653 bps in 2025, its largest moves.
  • Year by year, Gross Margin stood at 100.43% in 2022, then soared by 70 bps to 170.68% in 2023, then plunged by 226 bps to 214.35% in 2024, then surged by 143 bps to 92.19% in 2025, then gained by 2 bps to 93.85% in 2026.
  • Per Business Quant, the three latest QURE Gross Margin figures stand at 93.85% (Q1 2026), 92.19% (Q4 2025), and 89.25% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 88.95%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 91.79%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 90.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 uniQure 2.47 Bn 2.47 Bn 3.34 Mn 93.85%

Historic Data

Download Data
DateValue
Mar 31, 2026 93.85%
Dec 31, 2025 92.19%
Sep 30, 2025 89.25%
Jun 30, 2025 87.53%
Mar 31, 2025 87.43%
Dec 31, 2024 -214.35%
Sep 30, 2024 66.90%
Jun 30, 2024 97.90%
Mar 31, 2024 -6.97%
Dec 31, 2023 170.68%
Sep 30, 2023 28.50%
Jun 30, 2023 44.18%
Mar 31, 2023 54.27%
Dec 31, 2022 100.43%
Sep 30, 2022 40.58%
Jun 30, 2022 -67.40%
Dec 31, 2021 96.88%
Sep 30, 2021 100.00%
Jun 30, 2021 95.00%